Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001689375-23-000030
Filing Date
2023-04-19
Accepted
2023-04-19 17:52:12
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_168194111990641.html 4/A  
1 FORM 4/A wf-form4a_168194111990641.xml 4/A 6956
  Complete submission text file 0001689375-23-000030.txt   8389
Mailing Address C/O AMICUS THERAPEUTICS 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Doshi Dipal (Reporting) CIK: 0001613084 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40969 | Film No.: 23830930

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations